ARCH Venture Partners IX, LLC - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Partners IX, LLC since 12/22/2023

Holdings reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18.2M $41.5M $2.28 Jun 21, 2021 ARCH Venture Fund IX, L.P.
Common Stock 18.2M $41.5M $2.28 Jun 21, 2021 ARCH Venture Fund IX Overage, L.P.
Series A Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX, L.P. Common Stock
Series A Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX Overage, L.P. Common Stock
series C Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX, L.P. Common Stock
Series C Convertible Preferred Stock 0 Jun 21, 2021 ARCH Venture Fund IX Overage, L.P. Common Stock

Transactions reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.